The genetics of obsessive-compulsive disorder and Tourette's syndrome: What are the common factors?

Current Psychiatry Reports

Volumn 11, Issue 2, 2009, Pages 162-166

  Grados, Marco A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DULOXETINE; FLUOXETINE; MEMBRANE PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN SAPAP3; PROTEIN SCL1A1; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

EPIGENETICS; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GILLES DE LA TOURETTE SYNDROME; HAPLOTYPE; HUMAN; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; REACTION TIME; REVIEW; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TIC;

GENOTYPE; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PHENOTYPE; TOURETTE SYNDROME;

EID: 63549133694     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-009-0025-x     Document Type: Review

References (50)

1. Kamiya A, Tan PL, Kubo K, et al.: Recruitment of PCM1 to the centrosome by the cooperative action of DISC1 and BBS4: A candidate for psychiatric illnesses. Arch Gen Psychiatry 2008, 65:996-1006.
2. Welch JM, Lu J, Rodriguiz RM, et al.: Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007, 448:894-900.
3. Bjornsson HT, Fallin MD, Feinberg AP: An integrated epigenetic and genetic approach to common human disease. Trends Genet 2004, 20:350-358.
4. Kaminsky Z, Wang SC, Petronis A: Complex disease, gender and epigenetics. Ann Med 2006, 38:530-544.
5. Tongiorgi E, Baj G: Functions and mechanisms of BDNF mRNA trafficking. Novartis Found Symp 2008, 289:136-147.
6. Stark KL, Xu B, Bagchi A, et al.: Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet 2008, 40:751-760.
7. Cook EH Jr, Scherer SW: Copy-number variations associated with neuropsychiatric conditions. Nature 2008, 455:919-923.
8. Nestadt G, Samuels J, Riddle M, et al.: A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 2000, 57:358-363.
9. Hanna GL, Fischer DJ, Chadha KR, et al.: Familial and sporadic subtypes of early-onset obsessive-compulsive disorder. Biol Psychiatry 2005, 57:895-900.
10. Geller DA, Biederman J, Faraone S, et al.: Developmental aspects of obsessive compulsive disorder: Findings in children, adolescents, and adults. J Nerv Ment Dis 2001, 189:471-477.
11. Skoog G, Skoog I: A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1999, 56:121-127.
12. Shugart YY, Samuels J, Willour VL, et al.: Genomewide linkage scan for obsessive-compulsive disorder: Evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 2006, 11:763-770.
13. Hanna GL, Veenstra-VanderWeele J, Cox NJ, et al.: Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet 2002, 114:541-552.
14. Hanna GL, Veenstra-VanderWeele J, Cox NJ, et al.: Evidence for a susceptibility locus on chromosome 10p15 in early-onset obsessive-compulsive disorder. Biol Psychiatry 2007, 62:856-862.
15. Stewart SE, Fagerness JA, Platko J, et al.: Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:1027-1033.
16. Arnold PD, Sicard T, Burroughs E, et al.: Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 2006, 63:769-776.
17. Dickel DE, Veenstra-VanderWeele J, Cox NJ, et al.: Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry 2006, 63:778-785.
18. Grados M, Wilcox HC: Genetics of obseAsive-compulsive disorder: a research update. Expert Rev Neurother 2007, 7:967-980.
19. Leckman JF: Tourette's syndrome. Lancet 2002, 360:1577-1586.
20. Cohen AJ, Leckman JF: Sensory phenomena associated with Gilles de la Tourette's syndrome. J Clin Psychiatry 1992, 53:319-323.
21. Pauls DL, Leckman JF: The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. N Engl J Med 1986, 315:993-997.
22. Walkup JT, LaBuda MC, Singer HS, et al.: Family study and segregation analysis of Tourette syndrome: Evidence for a mixed model of inheritance. Am J Hum Genet 1996, 59:684-693.
23. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics. Am J Hum Genet 1999, 65:1428-1436.
24. Tourette Syndrome Association: Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. Am J Hum Genet 2007, 80:265-272.
25. Yoon DY, Rippel CA, Kobets AJ, et al.: Dopaminergic polymorphisms in Tourette syndrome: Association with the DAT gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet 2007, 144B:605-610.
26. Pauls DL, Leckman JF, Towbin KE, et al.: A possible genetic relationship exists between Tourette's syndrome and obsessive-compulsive disorder. Psychopharmacol Bull 1986, 22:730-733.
27. Grados MA, Mathews CA; the International Genetics Consortium of Gilles de la Tourette Syndrome: Latent class analysis of Gilles de la Tourette syndrome using comorbidities: Clinical and genetic implications. Biol Psychiatry 2008, 64:219-225.
28. Nestadt G, Di CZ, Riddle MA, et al.: Obsessive-compulsive disorder: subclassification based on co-morbidity. Psychol Med 2008 Dec 2 (Epub ahead of print).
29. Zhang H, Leckman JF, Pauls DL, et al.: Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet 2002, 70:896-904.
30. Bienvenu OJ, Wang Y, Shugart YY, et al.: Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study. Am J Med Genet B Neuropsychiatr Genet 2008 Dec 2 (Epub ahead of print).
31. Chamberlain SR, Blackwell AD, Fineberg NA, et al.: The neuropsychology of obsessive compulsive disorder: The importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev 2005, 29:399-419.
32. Eagle DM, Baunez C, Hutcheson DM, et al.: Stop-signal reaction-time task performance: Role of prefrontal cortex and subthalamic nucleus. Cereb Cortex 2008, 18:178-188.
33. Winter C, Flash S, Klavir O, et al.: The role of the subthalamic nucleus in "compulsive" behavior in rats. Eur J Neurosci 2008, 27:1902-1911.
34. Baup N, Grabli D, Karachi C, et al.: High-frequency stimulation of the anterior subthalamic nucleus reduces stereotyped behaviors in primates. J Neurosci 2008, 28:8785-8788.
35. Chamberlain SR, Menzies L, Hampshire A, et al.: Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008, 321:421-422.
36. Mirza NR, Nielsen EO, Troelsen KB: Serotonin transporter density and anxiolytic-like effects of antidepressants in mice. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:858-866.
37. Billett EA, Richter MA, King N, et al.: Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry 1997, 2:403-406.
38. McDougle CJ, Epperson CN, Price LH, et al.: Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry 1998, 3:270-273.
39. Di Bella D, Erzegovesi S, Cavallini MC, et al.: Obsessive-compulsive disorder, 5-HTTLPR polymorphism and treatment response. Pharmacogenomics J 2002, 2:176-181.
40. Zhang L, Liu X, Li T, et al.: Molecular pharmacogenetic studies of drug responses to obsessive-compulsive disorder and six functional genes [in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2004, 21:479-481.
41. Lane HY, Chang YC, Chiu CC, et al.: Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene. Am J Psychiatry 2002, 159:1593-1595.
42. Denys D, Van Nieuwerburgh F, Deforce D, et al.: Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial. J Clin Psychiatry 2007, 68:747-753.
43. Sanders AR, Duan J, Gejman PV: DNA variation and psychopharmacology of the human serotonin receptor 1B (HTR1B) gene. Pharmacogenomics 2002, 3:745-762.
44. Lafleur DL, Pittenger C, Kelmendi B, et al.: N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology (Berl) 2006, 184:254-256.
45. Pittenger C, Krystal JH, Coric V: Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx 2006, 3:69-81.
46. Stephenson FA: Subunit characterization of NMDA receptors. Curr Drug Targets 2001, 2:233-239.
47. Amaral OB, Roesler R: Targeting the NMDA receptor for fear-related disorders. Recent Pat CNS Drug Discov 2008, 3:166-178.
48. Nankai M, Klarica M, Fage D, Carter C: The pharmacology of native N-methyl-D-aspartate receptor subtypes: Different receptors control the release of different striatal and spinal transmitters. Prog Neuropsychopharmacol Biol Psychiatry 1998, 22:35-64.
49. Conn PJ, Lindsley CW, Jones CK: Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol Sci 2009, 30:25-31.
50. Mehler MF: Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol 2008, 86:305-341.